| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Costin Vlad Anastasiu | Q64964027 |
| Oana Gabriela Dimienescu | Q91718203 | ||
| P2093 | author name string | Andreea Bălan | |
| Marius Alexandru Moga | |||
| Victoria Burtea | |||
| Roxana Maria Dragomir | |||
| P2860 | cites work | Estrogen Receptor Subtypes in Ovarian Cancer | Q57706069 |
| MicroRNAs: components of an integrated system controlling cardiac development, physiology, and disease pathogenesis | Q58816196 | ||
| Role and Regulation of the Serum- and Glucocorticoid-Regulated Kinase 1 in Fertile and Infertile Human Endometrium | Q59102101 | ||
| miRBase: from microRNA sequences to function | Q63649149 | ||
| Plasma miRNAs Display Limited Potential as Diagnostic Tools for Endometriosis | Q63937986 | ||
| Immunohistochemistry expression of targeted therapies biomarkers in ovarian clear cell and endometrioid carcinomas (type I) and endometriosis. | Q64984163 | ||
| Non-Coding RNAs in Endometrial Physiopathology. | Q64994577 | ||
| Ovarian mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis | Q68248378 | ||
| Malignant changes in endometriosis | Q73269478 | ||
| Epithelial metaplastic changes in ovarian endometriosis | Q77162121 | ||
| The epidemiology of endometriosis | Q77930005 | ||
| Ovarian and extraovarian endometriosis-associated cancer | Q78383658 | ||
| MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases | Q83791670 | ||
| The Origin of Ovarian Cancer — Is It Getting Clearer? | Q85187684 | ||
| Circulating microRNAs identified in a genome-wide serum microRNA expression analysis as noninvasive biomarkers for endometriosis | Q85336910 | ||
| miRNA-199a-5p regulates VEGFA in endometrial mesenchymal stem cells and contributes to the pathogenesis of endometriosis | Q86580095 | ||
| Serum microRNA-92 expression in patients with ovarian epithelial carcinoma | Q87287824 | ||
| Adolescent endometriosis | Q87750649 | ||
| Disparity in endometriosis diagnoses between racial/ethnic groups | Q91593377 | ||
| Differential microRNA expression by Solexa sequencing in the sera of ovarian cancer patients | Q95567834 | ||
| The nuclear RNase III Drosha initiates microRNA processing | Q24295234 | ||
| Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs | Q24302072 | ||
| The Drosha-DGCR8 complex in primary microRNA processing | Q24318603 | ||
| MicroRNA maturation: stepwise processing and subcellular localization | Q24534359 | ||
| Real-time quantification of microRNAs by stem-loop RT-PCR | Q24535510 | ||
| Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs | Q24537328 | ||
| Characterization of extracellular circulating microRNA | Q24603537 | ||
| Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies | Q24619808 | ||
| Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
| miRNAs Regulation and Its Role as Biomarkers in Endometriosis | Q26771724 | ||
| MicroRNA profiling: approaches and considerations | Q26861675 | ||
| MicroRNAs - Biology and clinical applications | Q27024066 | ||
| Methodological challenges in utilizing miRNAs as circulating biomarkers | Q27027950 | ||
| Prediction of mammalian microRNA targets | Q27860498 | ||
| Nuclear export of microRNA precursors | Q27860686 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases | Q28131780 | ||
| RNAi, microRNAs, and human disease | Q28273238 | ||
| Human RISC couples microRNA biogenesis and posttranscriptional gene silencing | Q28280424 | ||
| ARID1A mutations in cancer: another epigenetic tumor suppressor? | Q28280605 | ||
| The human DiGeorge syndrome critical region gene 8 and Its D. melanogaster homolog are required for miRNA biogenesis | Q28297566 | ||
| MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins | Q29615034 | ||
| The MicroRNA Spectrum in 12 Body Fluids | Q29618068 | ||
| Biomarkers in endometriosis: challenges and opportunities | Q30238485 | ||
| The disparate origins of ovarian cancers: pathogenesis and prevention strategies. | Q30240709 | ||
| Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study | Q33551425 | ||
| The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory | Q33739695 | ||
| Roles of deletion of Arid1a, a tumor suppressor, in mouse ovarian tumorigenesis | Q33752609 | ||
| Epithelial to mesenchymal transition-like and mesenchymal to epithelial transition-like processes might be involved in the pathogenesis of pelvic endometriosis. | Q50519649 | ||
| Circulating miR-200-family micro-RNAs have altered plasma levels in patients with endometriosis and vary with blood collection time. | Q50533709 | ||
| miR-20a contributes to endometriosis by regulating NTN4 expression. | Q51073089 | ||
| Computational identification of microRNA targets. | Q52001642 | ||
| Serum MicroRNA Biomarkers Regulated by Simvastatin in a Primate Model of Endometriosis. | Q52627417 | ||
| Anticancer Activity of Toxins from Bee and Snake Venom-An Overview on Ovarian Cancer. | Q52644472 | ||
| Circulating miRNAs in Murine Experimental Endometriosis. | Q52912801 | ||
| Serum microRNAs in clear cell carcinoma of the ovary. | Q53161410 | ||
| Mutations and deletions of ARID1A in breast tumors. | Q54488231 | ||
| ACOG issues recommendations for the management of endometriosis. American College of Obstetricians and Gynecologists. | Q54541819 | ||
| The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform | Q54997659 | ||
| Evaluation of serum CA 125 levels in patients with pelvic pain related to endometriosis | Q57600572 | ||
| The relationship of endometriosis and ovarian malignancy: a review | Q37321246 | ||
| MicroRNA expression profiling of eutopic secretory endometrium in women with versus without endometriosis | Q37348044 | ||
| Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (review). | Q37541804 | ||
| Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes | Q37594361 | ||
| The role of microRNAs in endometriosis and associated reproductive conditions | Q37601781 | ||
| Ovarian cancer in endometriosis: epidemiology, natural history, and clinical diagnosis | Q37621316 | ||
| Accurate and objective copy number profiling using real-time quantitative PCR. | Q37671069 | ||
| Genome-wide survey of tissue-specific microRNA and transcription factor regulatory networks in 12 tissues | Q37738471 | ||
| Functional relevance of miRNA sequences in human disease. | Q37956470 | ||
| Role of microRNAs in gynecological pathology. | Q37997854 | ||
| Tissue and circulating microRNA influence reproductive function in endometrial disease | Q38140446 | ||
| Forensic miRNA: potential biomarker for body fluids? | Q38256477 | ||
| MicroRNAs and angiogenesis in endometriosis | Q38436356 | ||
| Analysis of Serum microRNA Profile by Solexa Sequencing in Women With Endometriosis | Q38444867 | ||
| Prevalence and Symptomatic Burden of Diagnosed Endometriosis in the United States: National Estimates from a Cross-Sectional Survey of 59,411 Women | Q39208376 | ||
| Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer. | Q44806064 | ||
| Serum microRNAs as diagnostic markers of endometriosis: a comprehensive array-based analysis | Q47797428 | ||
| Measurement of oxidative stress in the follicular fluid of infertility patients with an endometrioma | Q48572192 | ||
| The miRNA Mirage: How Close Are We to Finding a Non-Invasive Diagnostic Biomarker in Endometriosis? A Systematic Review | Q49804366 | ||
| Genomic analysis of human microRNA transcripts | Q34007864 | ||
| A polymorphism in a let-7 microRNA binding site of KRAS in women with endometriosis | Q34030553 | ||
| Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects | Q34033619 | ||
| Evidence that endometriosis behaves in a malignant manner. | Q34090884 | ||
| Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening | Q34122840 | ||
| Functional microRNA involved in endometriosis. | Q34173197 | ||
| The role of microRNAs in ovarian cancer | Q34253436 | ||
| Consensus on current management of endometriosis | Q34335288 | ||
| The differential expression of microRNA-143,145 in endometriosis. | Q34519505 | ||
| Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer | Q34526484 | ||
| Role of endometriosis in cancer and tumor development | Q34597390 | ||
| Endometriosis and ovarian cancer. | Q34657664 | ||
| Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer | Q35040690 | ||
| Endometriosis and ovarian cancer: a systematic review | Q35116887 | ||
| Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm | Q35140600 | ||
| ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers | Q35501591 | ||
| Circulating microRNAs as potential biomarkers for endometriosis | Q35562931 | ||
| Endometriosis and the development of malignant tumours of the pelvis. A review of literature | Q35780943 | ||
| MiR-199a attenuates endometrial stromal cell invasiveness through suppression of the IKKβ/NF-κB pathway and reduced interleukin-8 expression | Q35797389 | ||
| An overview of microRNAs | Q35858483 | ||
| MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions | Q35861521 | ||
| Ovarian clear cell adenocarcinoma: a continuing enigma | Q36026090 | ||
| Small regulatory RNAs in mammals | Q36088922 | ||
| Modulation of estrogenic action in clear cell carcinoma of the ovary (Review). | Q36224720 | ||
| Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms | Q36469640 | ||
| Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer | Q36679982 | ||
| RISCy business: MicroRNAs, pathogenesis, and viruses | Q36879784 | ||
| Real-time PCR quantification of precursor and mature microRNA. | Q37044773 | ||
| Plasma miR-17-5p, miR-20a and miR-22 are down-regulated in women with endometriosis | Q37069250 | ||
| MicroRNAs: biogenesis and molecular functions. | Q37069470 | ||
| MicroRNAs expression profiling of eutopic proliferative endometrium in women with ovarian endometriosis. | Q37153790 | ||
| Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma | Q37164133 | ||
| ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas | Q37225222 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P921 | main subject | endometriosis | Q205764 |
| biomarker | Q864574 | ||
| P577 | publication date | 2019-05-23 | |
| P1433 | published in | Journal of Clinical Medicine | Q27724774 |
| P1476 | title | Circulating miRNAs as Biomarkers for Endometriosis and Endometriosis-Related Ovarian Cancer-An Overview | |
| P478 | volume | 8 |
| Q90113970 | Biomarkers for the Noninvasive Diagnosis of Endometriosis: State of the Art and Future Perspectives |
| Q102152327 | Characterization of miR-200 family members as blood biomarkers for human and laying hen ovarian cancer |
Search more.